The Path Ahead: Medicines For Europe Head Highlights Opportunities And Risks
Examining The Future Landscape For Generics, Biosimilars And Value Added Medicines
• By David Wallace
Adrian van den Hoven looks to the future for off-patent medicines in Europe • Source: Medicines for Europe 
